LALPATHLABDr. Lal Path Labs Ltd.
Healthcare · Diagnostics & Research · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
The picture
- • Revenue growth: 16.6% YoY
- • ROE: 21.5%
- • ROCE: 37.9%
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • Supertrend: bullish
Bull case
- • Revenue growth: 16.6% YoY
- • ROE: 21.5%
- • ROCE: 37.9%
- • Price vs SMA200: above
Bear case
- • Profit growth: -15.4% YoY
- • MACD: bearish
- • Price vs EMA21: below
- • 1-month return: -3.6%
Key risks
- • Profit growth: -15.4% YoY
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹60.87). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.